BioWales 2012 Conference Programme
BioWales is our signature event, that brings the Life Sciences Sector together in Wales for 2 full days of stimulating conference and brokerage meetings.
This will be the 10th year for the event and we're taking the opportunity to re-launch it on a larger and more international scale which will better reflect the vision for Life Sciences in Wales.
The themes this year will showcase the Welsh Government's commitment to support Innovation, Translation and Commercialisation, in particular the focus on attracting private finance and experienced investors, and on finding, creating and supporting entrepreneurs who have the skills and appetite to commercialise research and grow businesses. The event aims to provide opportunities to inspire and to drive ambition and success, and demonstrate that Wales is a key location for Life Sciences research and enterprise.
Conference and Brokerage sessions will be separate this year to enable everyone to fully participate in both.
DAY ONE
8.00 - 10.00 Registration, Exhibition, coffee and networking
10.00 - 12.00 Keynote Speakers:
Professor Sir Christopher Evans, OBE
Chairman of the Life Science Sector Panel unveils the New and Vibrant Life Science Strategic direction for Wales, and answers your questions.
Sir Richard Sykes
Former Chairman of GlaxoSmithKline - opening address, sharing his experience and insights.
The Minister for Business, Enterprise Technology and Science
Professor Trevor Jones
Former Director General, Association of British Pharmaceutical Industry will discuss the current and future strategic direction of the Pharmaceutical Industry and the role of the SME business community.
12.00 - 2.00 Lunch, Brokerage meetings and Exhibition
2.00 - 3.15 Innovation:
Professor Chris McGuigan
Cardiff University discusses how technology developed within his lab resulted in a $2.5bn deal.
Gabriele Cerrone
Chairman of BioVitas Capital joins us from the USA to talk finance.
Dr David Bott
Director of Innovation Programmes Technology Strategy Board - Concept to Commercialisation in Life Sciences
John Jeans
Chairman, Cardiff University Council, Medical Research Council - Techonolgy, and Imanova Ltd discusses public funing of innovation in Life Sciences future challenges.
3.15 - 3.45 Coffee Break
3.45 - 4.45 Innovation Cont.
Ian James
Director A4P Consulting
Innovation in Clinical Bioanalysis
Dr Nick Thomas
Principal Scientist in Cell Technologies, GE healthcare talks about Innovating Pre-Clinical Drug Development; Towards an Integrated Approach to Investigate Toxicology in Human Models.
Rowan Gardner
Biolauncher New Models for BioScience Innovation.
4.00 - 6.00 Exhibition and Brokerage meetings
6.00 Drinks Reception
7.00 - 10.00 Gala Dinner and Medilink Awards
DAY TWO
8.00 - 10.00 Registration, Exhibition, coffee and networking
10.00 - 12.00 translation:
Michael Hunt
CEO of Renuron will outline developments in the use of stem cells therapies for stroke patients.
Berwyn Clarke
Board Director and Chief Scientific officer, Lab 21discusses companion diagnostics - a key component in modern science.
David Ford & Dr Steven Conlan, Institute of Life Science
'Whats the point of care' showing that research makes a difference.
Professor Jonathan Bisson
Clinical Director, NISCHR AHSC discusses bridging the gap between the NHS and Business.
Trevor Howe
Janssen, a Johnson and Johnson Company.
12.00 - 2.00 Lunch, Brokerage meetings and Exhibition
2.00 - 4.00 Commercialisation:
Michael Thompson
Managing Director, Biomet UK Healthcare discusses Rapid Knee Arthoplasty Patient Pathway - A service model for orthopedic care.
Kenneth Powell
Exectutive Chairman for Q Chip talks turning good science into commercial science - case histories from Biotechnology.
Dr Peter Corish
Head of Business Development, British Biocell International. Innovation versus Process - the balancing act for successful new product development in diagnostics.
3.15 - 3.35 Coffee Break
3.35 - 4.30 Facilitated Finance Panel
Brenig Preest
Investment Director, Excalibur Group Holdings Ltd.
Dr Melanie Goward
Senior Investment Executive, Finance Wales.
Dominic Griffiths
Senior Life Science Director, Fusion IP.
Workshops:
Day One:
1.15 - 1.45 UKTI Workshop.
Day Two:
1.15 - 1.45 GE Startup Workshop.